Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 939

1.

Essential Tremor and Parkinson's Disease: Exploring the Relationship.

Tarakad A, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2019 Jan 9;8:589. doi: 10.7916/D8MD0GVR. eCollection 2018. Review.

2.

The Wide Spectrum of Functional Movement Disorders.

Baizabal-Carvallo JF, Jankovic J.

JAMA Neurol. 2018 Dec 10. doi: 10.1001/jamaneurol.2018.3905. [Epub ahead of print] No abstract available.

PMID:
30535193
3.

MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.

Roncevic J, Djoric I, Selemetjev S, Jankovic J, Dencic TI, Bozic V, Cvejic D.

Pathology. 2019 Jan;51(1):55-61. doi: 10.1016/j.pathol.2018.10.008. Epub 2018 Nov 27.

PMID:
30497805
4.

Pathogenesis-targeted therapeutic strategies in Parkinson's disease.

Jankovic J.

Mov Disord. 2019 Jan;34(1):41-44. doi: 10.1002/mds.27534. Epub 2018 Nov 28. No abstract available.

PMID:
30484897
5.

Huntington disease: A quarter century of progress since the gene discovery.

Testa CM, Jankovic J.

J Neurol Sci. 2019 Jan 15;396:52-68. doi: 10.1016/j.jns.2018.09.022. Epub 2018 Sep 27. Review.

PMID:
30419368
6.

Dental service utilisation among adults in a European developing country: findings from a national health survey.

Šiljak S, Janković J, Marinković J, Erić M, Janevic T, Janković S.

Int Dent J. 2018 Oct 26. doi: 10.1111/idj.12449. [Epub ahead of print]

PMID:
30362506
7.

Author Correction: Dystonia.

Balint B, Mencacci NE, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP.

Nat Rev Dis Primers. 2018 Oct 19;4(1):37. doi: 10.1038/s41572-018-0039-y.

PMID:
30341354
8.

Predictors of alcohol responsiveness in dystonia.

Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Brüggemann N.

Neurology. 2018 Nov 20;91(21):e2020-e2026. doi: 10.1212/WNL.0000000000006551. Epub 2018 Oct 19.

PMID:
30341158
9.

Reader response: The nature of postural tremor in Parkinson disease.

Jankovic J.

Neurology. 2018 Oct 9;91(15):723. doi: 10.1212/WNL.0000000000006312. No abstract available.

PMID:
30297509
10.

Dystonia.

Balint B, Mencacci NE, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP.

Nat Rev Dis Primers. 2018 Sep 20;4(1):25. doi: 10.1038/s41572-018-0023-6. Review. Erratum in: Nat Rev Dis Primers. 2018 Oct 19;4(1):37.

PMID:
30237473
11.

Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.

Mitchell KT, Larson P, Starr PA, Okun MS, Wharen RE Jr, Uitti RJ, Guthrie BL, Peichel D, Pahwa R, Walker HC, Foote K, Marshall FJ, Jankovic J, Simpson R, Phibbs F, Neimat JS, Stewart RM, Dashtipour K, Ostrem JL.

Parkinsonism Relat Disord. 2018 Sep 6. pii: S1353-8020(18)30389-4. doi: 10.1016/j.parkreldis.2018.09.004. [Epub ahead of print]

PMID:
30220556
12.

Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.

Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE.

Mov Disord. 2018 Aug;33(8):1272-1280. doi: 10.1002/mds.27457. Epub 2018 Sep 7.

PMID:
30192018
13.

The Role of TMEM230 Gene in Parkinson's Disease.

Deng H, Fan K, Jankovic J.

J Parkinsons Dis. 2018;8(4):469-477. doi: 10.3233/JPD-181421.

14.

Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.

Telkes I, Viswanathan A, Jimenez-Shahed J, Abosch A, Ozturk M, Gupte A, Jankovic J, Ince NF.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8567-E8576. doi: 10.1073/pnas.1810589115. Epub 2018 Aug 21.

PMID:
30131429
15.

Relationship between socioeconomic and nutritional status in the Serbian adult population: a cross-sectional study.

Rakić JG, Maksimović M, Janković J, Vlajinac H, Marinković J.

Sao Paulo Med J. 2018 Jul-Aug;136(4):310-318. doi: 10.1590/1516-3180.2018.0038170418. Epub 2018 Aug 13.

16.

Assessment of hypertension chronic care model: Pacic application in Bosnia and Herzegovina.

Pilipovic-Broceta N, Vasiljevic N, Marinkovic J, Todorovic N, Jankovic J, Ostric I, Kalimanovska-Ostric D, Racic M.

PLoS One. 2018 Aug 14;13(8):e0202250. doi: 10.1371/journal.pone.0202250. eCollection 2018.

17.

Essential Tremor.

Jankovic J.

N Engl J Med. 2018 Aug 9;379(6):595. doi: 10.1056/NEJMc1807690. No abstract available.

PMID:
30091352
18.

Parkinson's disease tremors and serotonin.

Jankovic J.

Brain. 2018 Mar 1;141(3):624-626. doi: 10.1093/brain/awx361. No abstract available.

PMID:
30063797
19.

Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma.

Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM; Undiagnosed Diseases Network, Dhar SU.

Neurol Genet. 2018 Jul 20;4(4):e248. doi: 10.1212/NXG.0000000000000248. eCollection 2018 Aug. No abstract available.

20.

Botulinum Toxin for the Treatment of Hand Tremor.

Niemann N, Jankovic J.

Toxins (Basel). 2018 Jul 19;10(7). pii: E299. doi: 10.3390/toxins10070299.

21.

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.

Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C.

Mov Disord Clin Pract. 2018 Apr 26;5(3):273-282. doi: 10.1002/mdc3.12613. eCollection 2018 May-Jun.

22.

Pattern of Response to Bronchial Challenge with Histamine in Patients with Non-Atopic Cough-Variant and Classic Asthma.

Zugic V, Mujovic N, Hromis S, Jankovic J, Drvenica M, Perovic A, Kopitovic I, Ilic A, Nikolic D.

J Clin Med. 2018 Jul 12;7(7). pii: E174. doi: 10.3390/jcm7070174.

23.

Deutetrabenazine for the treatment of Huntington's chorea.

Bashir H, Jankovic J.

Expert Rev Neurother. 2018 Aug;18(8):625-631. doi: 10.1080/14737175.2018.1500178. Epub 2018 Jul 17.

PMID:
29996061
24.

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.

Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG.

JAMA Neurol. 2018 Oct 1;75(10):1206-1214. doi: 10.1001/jamaneurol.2018.1487.

25.

Consensus for the measurement of the camptocormia angle in the standing patient.

Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Volkmann J, Berg D, Deuschl G.

Parkinsonism Relat Disord. 2018 Jul;52:1-5. doi: 10.1016/j.parkreldis.2018.06.013. Epub 2018 Jun 8.

PMID:
29907329
26.

Preferred sampler inlet configurations for collection of aerosolized nano-scale materials.

Jankovic J, Zontek TL, Moore M, Ogle BR, Hollenbeck S.

Int J Occup Environ Health. 2018 Jan - Apr;24(1-2):1-6. doi: 10.1080/10773525.2018.1484995. Epub 2018 Jun 14.

PMID:
29902943
27.

Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats.

Djekic L, Janković J, Rašković A, Primorac M.

Eur J Pharm Sci. 2018 Jun 6;121:287-292. doi: 10.1016/j.ejps.2018.06.005. [Epub ahead of print]

PMID:
29883728
28.

Predictors of self-medication in Serbian adult population: cross-sectional study.

Tripković K, Nešković A, Janković J, Odalović M.

Int J Clin Pharm. 2018 Jun;40(3):627-634. doi: 10.1007/s11096-018-0624-x. Epub 2018 Mar 30.

PMID:
29603073
29.

Patterns of Health Care Utilization for Noncommunicable Diseases in a Transitional European Country: Results From the National Health Survey.

Janković J, Šiljak S, Marinković J, Kovač B, Janković S.

Int J Health Serv. 2018 Jan 1:20731418762717. doi: 10.1177/0020731418762717. [Epub ahead of print]

PMID:
29598810
30.

Cervical dystonia and substance abuse.

Mahajan A, Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, Barbano R, Perlmutter J, Patel N; members of the Dystonia Coalition.

J Neurol. 2018 Apr;265(4):970-975. doi: 10.1007/s00415-018-8840-9. Epub 2018 Mar 22.

PMID:
29569175
31.
32.

Tardive syndromes.

Savitt D, Jankovic J.

J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5. Review.

PMID:
29506749
33.
34.

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.

Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I; ENGENE-PSP Study.

Mov Disord. 2018 Mar;33(3):468-472. doi: 10.1002/mds.27336. Epub 2018 Feb 20.

PMID:
29460982
35.

The nosology of tardive syndromes.

Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA.

J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6.

PMID:
29433810
36.

Autoimmune and paraneoplastic movement disorders: An update.

Baizabal-Carvallo JF, Jankovic J.

J Neurol Sci. 2018 Feb 15;385:175-184. doi: 10.1016/j.jns.2017.12.035. Epub 2017 Dec 30. Review.

PMID:
29406902
37.

Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.

Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J.

Neurology. 2018 Feb 13;90(7):e559-e564. doi: 10.1212/WNL.0000000000004951. Epub 2018 Jan 17.

PMID:
29343468
38.

Leg stereotypy syndrome: phenomenology and prevalence.

Lotia M, York MK, Strutt AM, Jankovic J.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):692-695. doi: 10.1136/jnnp-2017-317057. Epub 2018 Jan 13.

PMID:
29332008
39.

Association between non-communicable disease multimorbidity and health care utilization in a middle-income country: population-based study.

Jankovic J, Mirkovic M, Jovic-Vranes A, Santric-Milicevic M, Terzic-Supic Z.

Public Health. 2018 Feb;155:35-42. doi: 10.1016/j.puhe.2017.11.014. Epub 2018 Jan 4.

PMID:
29306621
40.

The genetics of Parkinson disease.

Deng H, Wang P, Jankovic J.

Ageing Res Rev. 2018 Mar;42:72-85. doi: 10.1016/j.arr.2017.12.007. Epub 2017 Dec 26. Review.

PMID:
29288112
41.

Immunologic treatment of Parkinson's disease.

Jankovic J.

Immunotherapy. 2018 Feb;10(2):81-84. doi: 10.2217/imt-2017-0146. No abstract available.

PMID:
29260621
42.

Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J; International Parkinson’s Disease Genomics Consortium (IPDGC), Heutink P, Shulman JM.

Brain. 2017 Dec 1;140(12):3191-3203. doi: 10.1093/brain/awx285.

43.

Treatment options for chorea.

Bashir H, Jankovic J.

Expert Rev Neurother. 2018 Jan;18(1):51-63. doi: 10.1080/14737175.2018.1403899. Epub 2017 Nov 15. Review.

PMID:
29120264
44.

Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.

Stojisavljević D, Janković J, Erić M, Marinković J, Janković S.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):568-574. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.046. Epub 2017 Oct 31.

PMID:
29097061
45.

Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?

Jankovic J.

Nat Rev Neurol. 2017 Nov;13(11):643-644. doi: 10.1038/nrneurol.2017.140. Epub 2017 Sep 29. No abstract available.

PMID:
28960185
46.

The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.

Oshima M, Deitiker P, Jankovic J, Atassi MZ.

Immunol Invest. 2018 Jan;47(1):18-39. doi: 10.1080/08820139.2017.1368544. Epub 2017 Sep 11.

PMID:
28891721
47.

An update on new and unique uses of botulinum toxin in movement disorders.

Jankovic J.

Toxicon. 2018 Jun 1;147:84-88. doi: 10.1016/j.toxicon.2017.09.003. Epub 2017 Sep 6. Review.

PMID:
28888928
48.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

49.

Treatable inherited rare movement disorders.

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders.

Mov Disord. 2018 Jan;33(1):21-35. doi: 10.1002/mds.27140. Epub 2017 Sep 1. Review.

50.

Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule.

Deitiker P, Oshima M, Jankovic J, Atassi MZ.

Immunol Lett. 2017 Oct;190:257-264. doi: 10.1016/j.imlet.2017.07.016. Epub 2017 Aug 16.

PMID:
28823519

Supplemental Content

Loading ...
Support Center